Two Sigma Securities’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Two Sigma Securities’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-19,177	Closed	-$6K	–	3194
2018 Q1	$6K	Buy	19,177 +8,794	+85%	+$13.1K	﹤0.01%	2623
2017 Q4	$17K	Sell	10,383 -38,935	-79%	-$67K	﹤0.01%	1641
2017 Q3	$71K	Buy	+49,318	New	+$70.1K	0.01%	706
2017 Q1	–	Sell	-1,467	Closed	-$8K	–	1217
2016 Q4	$8K	Buy	+1,467	New	+$25.4K	﹤0.01%	682

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Two Sigma Securities's ANTH Position: Q2 2018 in Review

Two Sigma Securities sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 19,177 shares — an estimated $6K sold.

Two Sigma Securities first reported a position in ANTH in Q4 2016 and held it in 4 quarters. The position peaked at $71K in Q3 2017. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

Two Sigma Securities reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Two Sigma Securities sold 19,177 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $6K.
Two Sigma Securities first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
Two Sigma Securities's Anthera Pharmaceuticals, Inc. position peaked at $71K in Q3 2017.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Two Sigma Securities's 13F filing for Q2 2018, filed 14 Aug 2018.